Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Navis

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Pharmacological and Toxicological Methods|December 22, 1999
Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosisF H Wapstra, H van Goor, P E de Jong, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuriaG D Laverman, R H Henning, P E de Jong, et al.
Journal of the American Society of Nephrology : JASN|November 30, 1999
Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic ratsE De Boer, G Navis, A T Tiebosch, et al.
Kidney International. Supplement|July 21, 1999
Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiableE de Boer, G Navis, F H Wapstra, et al.
Clinical Science (London, England : 1979)|May 1, 1996
Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosisF H Wapstra, H Van Goor, G Navis, et al.
Journal of Pharmacological and Toxicological Methods|May 22, 1998
Sample dilution: a methodological pitfall in the measurement of tissue but not serum ace-activityJ Koiter, G Navis, P E de Jong, et al.
Journal of Cardiovascular Pharmacology|August 13, 1999
Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive ratsP A de Vries, G Navis, P E de Jong, et al.
Journal of Cardiovascular Pharmacology|June 1, 1987
Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patientsG Navis, P de Jong, A J Donker, et al.
Kidney International|March 1, 1987
Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibitionG Navis, P E de Jong, A J Donker, et al.
Journal of Clinical Hypertension|September 1, 1985
Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertensionG Navis, P E de Jong, A J Donker, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Pharmacological and Toxicological Methods|December 22, 1999
Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosisF H Wapstra, H van Goor, P E de Jong, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 2001
Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuriaG D Laverman, R H Henning, P E de Jong, et al.
Journal of the American Society of Nephrology : JASN|November 30, 1999
Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic ratsE De Boer, G Navis, A T Tiebosch, et al.
Kidney International. Supplement|July 21, 1999
Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiableE de Boer, G Navis, F H Wapstra, et al.
Clinical Science (London, England : 1979)|May 1, 1996
Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosisF H Wapstra, H Van Goor, G Navis, et al.
Journal of Pharmacological and Toxicological Methods|May 22, 1998
Sample dilution: a methodological pitfall in the measurement of tissue but not serum ace-activityJ Koiter, G Navis, P E de Jong, et al.
Journal of Cardiovascular Pharmacology|August 13, 1999
Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive ratsP A de Vries, G Navis, P E de Jong, et al.
Journal of Cardiovascular Pharmacology|June 1, 1987
Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patientsG Navis, P de Jong, A J Donker, et al.
Kidney International|March 1, 1987
Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibitionG Navis, P E de Jong, A J Donker, et al.
Journal of Clinical Hypertension|September 1, 1985
Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertensionG Navis, P E de Jong, A J Donker, et al.
Pageof 7